Safe and Comfort
Multi-station temperature monitoring: NF5 is equipped with 3 temperature sensors, which can realize real-time temperature monitoring, synchronous closed-loop feedback, combined high temperature alarm, intelligent water level management and over-temperature protection functions to ensure safer heating.
High-performance nasal cannula: ergonomic design, soft and comfortable, without restraint.
Ultra-quiet design: Ultra-quiet turbine significantly reduces noise, provides a quiet oxygen treatment environment, and reduces irritability.
Fight the epidemic together
New coronavirus pneumonia (NCP) is pneumonia caused by SARS-CoV-2 infection.
Severe and critically ill patients often have hypoxemia, dyspnea and normal breathing.
Need supportive treatment.
As described in the "Expert Consensus on the Use and Management of HFNC Patients" New Coronavirus Pneumonia", it is used for acute hypoxic respiratory failure and high-flow nasal oxygen.
HFNC therapy has greater advantages than traditional O2 therapy.
Clinical application
Mild respiratory distress (respiratory rate >24 bpm)
ARDS and other type I respiratory failure
(100 mmHg ≤ PaO2/FiO2 <300 mmHg)
Type II respiratory failure
Invasive ventilation
Efficient and precise
One-button oxygen flush
Rapidly increase O2 concentration, increase the patient’s O2 reserve,
Harmonizing phlegm aspiration, bronchoscopy, intubation and other nursing care.
High-precision oxygen concentration control
Adopt high-precision electronic air-O2 mixing system and precise O2 concentration monitoring module. Achieve precise control and real-time monitoring of O2 concentration
Intelligent temperature and humidity control
Through intelligent temperature and humidity monitoring and closed-loop feedback mechanism, NF5 provides patients with accurate high-flow O2 treatment
Close to natural body temperature (37℃) and 100% relative humidity (44mg/L),
Optimize mucus and cilia function.
Wide range of applications
2- 80L/min wide-range flow control can effectively flush the dead space (physiology), avoid CO2 retention, meet the treatment needs of infants and adults, and is clinically suitable for different age groups.
Adult treatment range:
10~80L/min
Comply with "Expert Consensus" on clinical standardized application
HFNC "adult", the latest requirement of respiratory flow is 8~80L/min.
